Continue reading this on our app for a better experience

Open in App
Home News Covid-19

Moderna says it has US$18.5 billion in vaccine orders for 2022

Bloomberg
Bloomberg • 1 min read
Moderna says it has US$18.5 billion in vaccine orders for 2022
Analysts were expecting US$19.3 billion in Moderna Covid vaccine sales for 2022
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Moderna Inc. said it has signed vaccine purchase agreements worth US$18.5 billion ($25.1 billion) for this year, along with options for another US$3.5 billion, including booster shots.

In a statement on Monday, the company also said 2021 product sales would be US$17.5 billion, slightly higher than the average analyst estimate of US$17 billion, according to data compiled by Bloomberg. Additionally, the company said that it shipped 807 million vaccine doses in 2021. Previously, it had said it would deliver between 700 million and 800 million doses.

The advance purchase agreements for 2022 are up from US$17 billion worth of commitments it had announced last year. Analysts were expecting US$19.3 billion in Moderna Covid vaccine sales for 2022, according to a Bloomberg survey of analyst estimates.

In premarket trading in New York, Moderna shares were up 0.2%.

Moderna announced the advance orders on the first day of the JPMorgan Healthcare Conference, where it is scheduled to present Monday morning.

Photo: Bloomberg

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.